Contact US

+86 18721174739

Email

jiyebio@jeyoupharma.com

Production services

Test Service Items

Development Services

Registration

Sales Outsourcing Services

Cell Line Developemnt

A single-cell clone with expression levels exceeding 6 g/L could be obtained within 3 months, and the establishment of the primary cell bank could be completed within 4 months.

A compliant and mature commercial cell line development platform could ensure optimal CMC developability and guarantee commercial benefits.

Single Cell Imager

Flow Cytometer

Cell Freezing and Dispensing

Pipetting Workstation

Process Development

  • Platform-Based Process Development Strategy
  • Accelerates development of robust and commercial processes
  • Optional use of qualified domestic material and consumables to reduce COGS

Process Characterization & Validation

Process Characterization (PC)

Process Characterization & Validation:

  • Critical Pathways to Drug Approval
  • A systematic approach to: Deliberately vary critical process parameters (CPPs)
  • Establish their impact on critical quality attributes (CQAs)
  • Define proven acceptable ranges (PARs) for commercial manufacturing

 

Purpose:

  • Ensure consistent product quality through science-based process controls.

Process Validation (PV)

Refers to the collection and evaluation of data from process design to commercial production, so as to demonstrate that the process can produce products consistently and comply with quality standards.

Analytical Method Development Services — Providing Scientific and Precise Solutions for Your Drug Development.

Leading Scientific Service Team

As a leading CDMO partner, we provide comprehensive analytical method development services for biological drugs. By our experienced scientific team and laboratories compliant with cGMP/GLP standards, we can develop HPLC/UPLC, CE, Marius and bioassay methods for clients, ensuring the specificity, sensitivity, and robustness of the methods.

Focused on Drug R&D

We specialize in forced degradation studies, stability-indicating methods, impurity identification and quantification, supporting your drugs from early-stage R&D to commercialization. By optimizing the method development process through the QbD (Quality by Design) approach, we ensure data reliability and compliance, accelerating your IND/NDA/BLA submissions.